Markets:

Overview

News

Currencies

International

Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

Verve Therapeutics Inc (NASDAQ:VERV): A High-Growth Momentum Stock Aligned with Minervini’s Trend Model ↗

August 02, 2025

Verve Therapeutics (VERV) aligns with Minervini’s trend model, showing strong technicals, 93% 3-month growth, and 479% revenue surge—ideal for high-growth investors.

Via Chartmill

3 Bullish Biotech Stocks With Explosive Growth Trends ↗

July 21, 2025

These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies

Via MarketBeat

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook ↗

July 15, 2025

Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.

Via MarketBeat

Topics Economy Stocks

VERVE THERAPEUTICS INC (NASDAQ:VERV) - A High-Growth Biotech Stock Meeting Minervini's Criteria ↗

July 09, 2025

VERVE THERAPEUTICS (VERV) is a high-growth biotech stock meeting Minervini's Trend Template criteria, with strong revenue growth, bullish technicals, and upward earnings revisions.

Via Chartmill

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week ↗

June 20, 2025

Via The Motley Fool

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst ↗

June 18, 2025

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.

Via Benzinga

This Verve Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗

June 18, 2025

Via Benzinga

Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN) ↗

June 18, 2025

Wall Street stays cool despite geopolitical tension, weak retail data, and a meltdown in solar stocks.

Via Chartmill

5 Analysts Assess Verve Therapeutics: What You Need To Know ↗

June 17, 2025

Via Benzinga

These stocks are moving in today's session ↗

June 17, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 17, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

June 17, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Why Verve Therapeutics Stock Is Skyrocketing Today ↗

June 17, 2025

Via The Motley Fool

Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday ↗

June 17, 2025

Via Benzinga

Which stocks are gapping on Tuesday? ↗

June 17, 2025

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’ ↗

June 17, 2025

Lilly will acquire all outstanding shares of Verve for $10.50 per share in cash payable at closing, in addition to a contingent value right (CVR) per share that entitles holders to $3 per share,...

Via Stocktwits

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover ↗

June 17, 2025

The companies were already collaborating on a handful of cardiovascular-focused gene-editing treatments.

Via Investor's Business Daily

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs ↗

June 17, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

June 17, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 17, 2025

Via Benzinga

Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition ↗

June 17, 2025

Eli Lilly is acquiring Verve Therapeutics to strengthen its cardiovascular pipeline with a gene-editing drug targeting PCSK9-linked conditions.

Via Benzinga

Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

June 17, 2025

Via Benzinga

Verve Therapeutics Soars 75% After-Hours Following Report Of $1.3B Eli Lilly Takeover Talks ↗

June 16, 2025

The deal would double Verve’s market value and expand Lilly’s pipeline of early-stage therapies.

Via Stocktwits

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst ↗

May 07, 2025

CRISPR reports data showing dose-dependent lipid reduction and strong safety, with plans to present full results in late 2025.

Via Benzinga

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street ↗

April 29, 2025

Via The Motley Fool

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗

April 21, 2025

Via Benzinga

Why Verve Therapeutics Zoomed 40% Higher This Week ↗

April 18, 2025

Via The Motley Fool

Topics Intellectual Property

Unusual volume stocks are being observed in Tuesday's session. ↗

April 15, 2025

Let's have a look at the stocks with an unusual volume in today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.